Risk Factors for Subsequent Recurrent, Relapsing, and Repeat Peritonitis in Peritoneal Dialysis

Clicks: 12
ID: 331551
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #204 of 228 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 228 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Peritoneal dialysis (PD)-associated peritonitis may be followed by recurrent, relapsing, or repeat episodes, but factors associated with these subsequent phenotypes remain incompletely defined. Methods We conducted a 16-year episode-based study of PD-associated peritonitis. Episodes after which PD was not continued were excluded, and outcomes were defined by the next peritonitis episode. The broader outcome was subsequent recurrent/relapsing/repeat peritonitis, and the narrower outcome was subsequent relapsing/repeat peritonitis. Patient-level and PD prescription-related factors were evaluated for the broader outcome, whereas acute microbiology, antibiotic-management, and severity factors were evaluated for the narrower outcome using logistic generalized estimating equation models. Cross-outcome analyses evaluated both predictor domains against both outcomes. Results Among 385 PD-associated peritonitis episodes from 216 patients, 275 episodes from 152 patients were included. Subsequent recurrent/relapsing/repeat peritonitis occurred after 63 episodes. Male sex was associated with lower odds of this outcome, whereas diabetes mellitus, current recurrent/relapsing/repeat phenotype, fewer APD treatment days, and greater manual exchange burden were associated with higher odds. However, the two prescription measures were strongly inversely correlated, and neither remained significant when mutually adjusted. Subsequent relapsing/repeat peritonitis occurred after 57 episodes. Ineffective initial antibiotic therapy and delayed adequate antibiotic therapy were associated with higher odds. Organism group and acute severity markers were not significantly associated with this outcome after adjustment. Cross-outcome analyses were broadly compatible with the main findings. Conclusions Patient vulnerability, recent episode history, PD prescription-related patterns, and antibiotic-management factors were associated with subsequent peritonitis phenotypes among patients who continued PD. These findings may inform post-peritonitis risk assessment.
Reference Key
openalex_W7220654660 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hong‐Mou Shih, Cheng-Jui Lin, Yi-Zhen Lu, Yu-Wen Hsueh, Chih-Jen Wu, Chi‐Feng Pan
Are you one of these authors? Claim your profile
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag352
URL
https://doi.org/10.1093/ckj/sfag352
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.